Skip to main content
. Author manuscript; available in PMC: 2023 Aug 17.
Published in final edited form as: Eur J Epidemiol. 2017 Aug 30;32(12):1075–1088. doi: 10.1007/s10654-017-0299-y

Table 4.

Multivariate regression model to assess the relationship of neonatal length (crown-heel length, cm) with fetal dose

Parameter estimate (+95% CI) 2-sided P value
Fetal dose (cm/Gy) −0.577 (−1.392, 0.259)   0.169
Trimester 1 versus trimester 3 −0.176 (−0.456, 0.010)   0.212
Trimester 2 versus trimester 3 −0.153 (−0.407, 0.114)   0.248
Parity ≥1 versus parity 0   0.415 (0.178, 0.655) <0.001
Gestation weeks (cm/week)   0.597 (0.486, 0.751) <0.001
Baby sex female versus baby sex male −0.818 (−1.054, −0.597) <0.001
Twin versus singleton −1.789 (−2.606, −0.408)   0.010
Maternal age (cm/year)   0.021 (−0.015, 8.900)   1.000
Maternal height (cm/cm)   0.069 (0.029, 0.503) <0.001a
Maternal weight at 1st clinic (cm/kg)   0.021 (−0.042, 0.056)   0.370
Model with separate dose × trimester
  Dose in trimester 1 (cm/Gy)   4.241 (−28.123, 28.242)   0.739
  Dose in trimester 2 (cm/Gy) −0.032 (−1.003, 1.481)   0.956
  Dose in trimester 3 (or missing) (cm/Gy) −1.120 (−2.673, −0.001)   0.049a
Linear quadratic model in dose
  Linear dose (cm/Gy) −0.484 (−2.181, 1.372)   0.597
  Quadratic dose (cm/Gy2) −0.100 (−1.684, 1.468)   0.902
a

P value derived from BCA-confidence intervals via Normal distribution

All regressions evaluated using 4999 bootstrap resamples. Model adjusted for trimester of exposure, parity, gestation weeks, baby’s sex, singleton/twin birth, maternal age at delivery of offspring, maternal height and maternal weight at first clinic visit. The estimates for the constant term and for indicators of covariate missingness are not given. Analysis of n = 1733 persons with non-missing data on neonatal length and fetal dose